Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Zinc is crucial for health, and deficiency can lead to immune, digestive, skin, and metabolic issues.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Urban air pollution worsens hair loss in alopecia areata by increasing immune response.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

A special diet can significantly reduce skin problems in dogs.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Exosomes show promise for diagnosing and treating skin conditions and hair loss.

Recent selection on immune response genes was identified across seven ethnicities.

Moderate immune responses help hair growth, while excessive responses slow it down.

Blocking GPR91 can help prevent and reverse hair loss in androgenetic alopecia.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Removing GRK2 in skin cells causes hair loss similar to immune-related alopecia.

Treatments for hair loss focus on targeting the immune system.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Inhibiting TYK2 can restore hair growth in alopecia areata.